Based on the expression of matriptase, HAI-1, and Her2 in breast cancers evaluated in these previous studies, a case can be made for examining the interplays of Her2, matriptase, and HAI-1 in breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.